Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
June 6, 2016
APREA AB ANNOUNCES EFFICACY AND SAFETY DATA IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENTS TREATED WITH INVESTIGATIONAL APR-246 PRESENTED AT 2016 ASCO ANNUAL MEETING
June 2, 2016
ACHAOGEN AWARDED $20 MILLION CONTRACT OPTION BY BARDA TO SUPPORT DEVELOPMENT OF PLAZOMICIN FOR MULTI-DRUG RESISTANT GRAM-NEGATIVE INFECTIONS
May 31, 2016
FDA GRANTS QIDP AND FAST TRACK DESIGNATION TO CD101 TOPICAL, CIDARA THERAPEUTICS’ NOVEL ANTIFUNGAL PRODUCT CANDIDATE
May 31, 2016
5AM VENTURES RAISES $285 MILLION LIFE SCIENCE VENTURE CAPITAL FUND
May 17, 2016
PURIGEN BIOSYSTEMS RECEIVES $18.2M IN SERIES A FINANCING LED BY 5AM VENTURES AND ROCHE VENTURE FUND
May 10, 2016
STORA ENSO STRENGTHENS BIO-BASED CHEMICALS DEVELOPMENT AND SIGNS A JOINT TECHNOLOGY DEVELOPMENT AND LICENSE AGREEMENT WITH RENNOVIA
May 9, 2016
EPIRUS ANNOUNCES REPRIORITIZATION OF PIPELINE TO SOLELY FOCUS ON BIOSIMILARS TO TREAT RARE DISEASES AND KEY LEADERSHIP CHANGES
May 3, 2016
IDEAYA BIOSCIENCES RAISES $46 MILLION SERIES A AND RECRUITS LEADERSHIP AND ADVISORY BOARD
May 2, 2016
HOMOLOGY MEDICINES EMERGES WITH NEXT GENERATION GENE EDITING TECHNOLOGY DRIVEN BY INDUSTRY-LEADING TEAM IN RARE DISEASES
April 21, 2016
VIVEVE® ANNOUNCES POSITIVE TOPLINE RESULTS FOR VIVEVE I CLINICAL TRIAL
« Previous Page
1
…
93
94
95
96
97
…
119
Next Page »